Amsterdam Health & Technology Center
The AVS @ AHTC is a top-notch working space consisting of 6 furnished offices and some flexdesks with many services provided. It is situated on the 5th floor of the D-tower. The target audience are health (tech) startups.
The AVS @AHTC is run by ahti, the Amsterdam health & technology institute, which sets out to improve the health of the city and her citizens. HealthInc is the new accelerator program of ahti together with Amsterdam UMC, location AMC. It offers an intensive full-time twelve-week program for early stage health and technology entrepreneurs.
At the heart of the Amsterdam Life Sciences District, in the southeast of Amsterdam, is the Amsterdam Health & Technology Center (AHTC). It is an entrepreneurial hub connecting start-up and scale-up companies in health, research, and technology, as well as accelerators and investors.
Amsterdam UMC, location AMC is one of the foremost medical research institutions in the Netherlands, as well as one of its largest hospitals. With its 30,000 m2, the AHTC/AMC location is one big health tech community. Here, leading medical research facilities and health-related companies form an ecosystem of support for innovation.
Caelus Health develops Microbiome Therapeutics that reduces the risk of developing diabetes. Luc Sterkman, CEO: “The University of Amsterdam – AMC in particular – created the first crucial data and patents, helping us to attract external funding. IXA managed the patent portfolio, established the first licensing contracts and also helped us to secure a proof-of-concept grant of 100,000 euros”.
Please contact us
Amsterdam UMC spin-off PacingCure is the winner of the Venture Challenge at the online edition of the Dutch Life Science Conference on the 26th of November. PacingCure develops precision gene therapies for common cardiac arrhythmias and cardiomyopathies, aiming to restore the natural pacing of the heart. The company is founded on combined research from the […]News
In their quest of creating safe and effective immunotherapy cancer treatments, VU spinoff LUMICKS and Amsterdam UMC spinoff LAVA Therapeutics joined forces. The partnership aims to evaluate the efficacy of various tumor-specific γδ T-cell engagers based on the resulting binding strengths (cell avidity) between T cells and tumors, measured with LUMICKS newly installed z-Movi® Cell […]News
VU startup Sports-f(x) is uitgeroepen tot winnaar van de 12e Dutch Sports Innovation Award 2020. Oprichter Nilas van Woersem ontving de prijs uit handen van jurylid Jan Hoefnagels voor de NextRound Boxing Bag, een slimme bokszak die direct feedback geeft. De Dutch Sports Innovation Award is de stimuleringsprijs voor een innovatief en kansrijk product of […]News